Knee replacement market

With the global prevalence of osteoarthritis and other knee illnesses such as psoriatic arthritis and rheumatoid arthritis on the rise, demand for knee replacement surgery is projected for continued, strong growth.

Source: https://www.skyquestt.com/report/knee-replacement-market
ICONS: ADOBE STOCK

790,000

total knee replacements, yearly

Market value

2022 - $10.34 billion

2023 - $10.93 billion

2031 - $16.99 billion

Growth rate to 2031 - 5.67% (CAGR)

Largest segment

Fixed-bearing implants

Fastest growth

Mobile-bearing implants

FYI

According to the Arthritis Foundation, around 1 million people in the United States have symptomatic knee osteoarthritis.

According to the BMJ Journal, being overweight or obese raised the incidence of knee osteoarthritis 2.5x to 4.6x compared to being normal weight.

An aging population and increased desire for less invasive surgical procedures are likely to fuel strong growth rate in the coming years.

The partial knee arthroplasty sector is expected to grow at a substantial CAGR during the forecast period because of prominent market players involved in developing innovative partial knee implants.

Market leaders

Stryker Corp.

Zimmer Biomet Holdings Inc.

Smith & Nephew plc

Johnson & Johnson (DePuy Synthes)

Medacta Int’l SA

MicroPort Scientific Corp.

DJO Global Inc.

Exactech Inc.

ConforMIS Inc.

Arthrex Inc.

June 2024
Explore the June 2024 Issue

Check out more from this issue and find your next story to read.